Back

Surveillance for Opioid-Associated Amnestic Syndrome in Canada, 2010-2022

Barash, J.

2024-10-27 neurology
10.1101/2024.10.24.24315474 medRxiv
Show abstract

ObjectivesA single diagnostic code could be used to perform surveillance for opioid-associated amnestic syndrome (OAS) in healthcare datasets on a national scale. MethodsA request was submitted to search the Discharge Abstract Database (DAD) and the National Ambulatory Care Reporting System (NACRS) in Canada for the ICD-10-CA code, F11.6 (mental and behavioural disorders due to use of opioids, amnesic syndrome) during fiscal years (FY) 2010-2011 through 2022-2023. The annual total of encounters using this code was determined and crude rates per million were calculated for the Canadian population represented. ResultsNational counts from DAD and NACRS combined ranged from <5 to 14 annually. Rates per million for available years fell between 0.17 and 0.48. For available data through FY 2015-2016, the mean number of annual combined encounters nationally was 6.3; for those years after, the mean was 10. The mean rate per million was 0.23 and 0.35 for these two periods, respectively. DiscussionThis study represents the first effort to conduct surveillance for OAS on a national scale and suggests that the condition is relatively rare. Future efforts to validate the coded diagnosis of OAS with confirmed cases will help determine its value as a surveillance tool.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.